493 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 10 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ATP11CATPase, class VI, type 11CEnzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP12AATPase, H+/K+ transporting, nongastric, alpha polypeptideEnzymes
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ATP13A1ATPase type 13A1Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Expressed in all
ATP13A2ATPase type 13A2Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP13A3ATPase type 13A3Predicted membrane proteins
Expressed in all
ATP13A4ATPase type 13A4Disease related genes
Predicted membrane proteins
Tissue enhanced
ATP13A5ATPase type 13A5Predicted membrane proteins
Tissue enhanced
ATP1A1ATPase, Na+/K+ transporting, alpha 1 polypeptideCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP1A2ATPase, Na+/K+ transporting, alpha 2 polypeptideDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Group enriched
ATP1A3ATPase, Na+/K+ transporting, alpha 3 polypeptideDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
ATP1A4ATPase, Na+/K+ transporting, alpha 4 polypeptideEnzymes
Predicted membrane proteins
Group enriched
ATP2A1ATPase, Ca++ transporting, cardiac muscle, fast twitch 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
ATP2A2ATPase, Ca++ transporting, cardiac muscle, slow twitch 2Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP2A3ATPase, Ca++ transporting, ubiquitousEnzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
ATP2B1ATPase, Ca++ transporting, plasma membrane 1Enzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
ATP2B2ATPase, Ca++ transporting, plasma membrane 2Enzymes
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ATP2B3ATPase, Ca++ transporting, plasma membrane 3Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Group enriched
ATP2B4ATPase, Ca++ transporting, plasma membrane 4Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP2C1ATPase, Ca++ transporting, type 2C, member 1Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Expressed in all
ATP2C2ATPase, Ca++ transporting, type 2C, member 2Enzymes
Predicted membrane proteins
Transporters
Tissue enhanced
ATP4AATPase, H+/K+ exchanging, alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
ATP8A1ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP8A2ATPase, aminophospholipid transporter, class I, type 8A, member 2Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Group enriched
ATP8B1ATPase, aminophospholipid transporter, class I, type 8B, member 1Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Mixed
ATP8B2ATPase, aminophospholipid transporter, class I, type 8B, member 2Enzymes
Predicted membrane proteins
Expressed in all
ATP8B3ATPase, aminophospholipid transporter, class I, type 8B, member 3Enzymes
Predicted membrane proteins
Tissue enriched
ATP8B4ATPase, class I, type 8B, member 4Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ATP9AATPase, class II, type 9AEnzymes
Predicted membrane proteins
Expressed in all
ATP9BATPase, class II, type 9BEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1BCalcium channel, voltage-dependent, N type, alpha 1B subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1ECalcium channel, voltage-dependent, R type, alpha 1E subunitPredicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CACNA1FCalcium channel, voltage-dependent, L type, alpha 1F subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1GCalcium channel, voltage-dependent, T type, alpha 1G subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1HCalcium channel, voltage-dependent, T type, alpha 1H subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1ICalcium channel, voltage-dependent, T type, alpha 1I subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1SCalcium channel, voltage-dependent, L type, alpha 1S subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CASD1CAS1 domain containing 1Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
CEPT1Choline/ethanolamine phosphotransferase 1Enzymes
Predicted membrane proteins
Expressed in all
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CHPT1Choline phosphotransferase 1Enzymes
Predicted membrane proteins
Expressed in all
CLCN1Chloride channel, voltage-sensitive 1Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CLCN2Chloride channel, voltage-sensitive 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
CLCN3Chloride channel, voltage-sensitive 3Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
CLCN4Chloride channel, voltage-sensitive 4Predicted membrane proteins
Transporters
Tissue enhanced
CLCN5Chloride channel, voltage-sensitive 5Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
CLCN6Chloride channel, voltage-sensitive 6Plasma proteins
Predicted membrane proteins
Expressed in all
CLCN7Chloride channel, voltage-sensitive 7Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Expressed in all

« prev | Page of 10 | next »